Recent Analyst Forecasts and Stock Ratings
NGM Biopharmaceuticals, Inc. FAQ's
What analysts cover NGM Biopharmaceuticals, Inc.?
NGM Biopharmaceuticals, Inc. has been rated by research analysts at Raymond James, Goldman Sachs in the past 90 days.